Activity value 85International Buyer&Supplier,Last transaction date:
2026-06-16Address: china,shanhai,room 1709-1710 hitech plaza 488 s.
Overview
Contact
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for aurisco pharmaceutical co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 35 transactions, with a transaction quantity of 8300.42 and a transaction weight of 16312.
Product description
СУБСТАНЦІЯ ДЛЯ ФАРМАЦЕВТИЧНОГО ЗАСТОСУВАННЯ ДЛЯ ЛЮДЕЙ АМІНОСПОЛУКИ ПРЕГАБАЛІН PREGABALIN ПОРОШОК СУБСТАНЦІЯ В ПОДВІЙНИХ П Е ПАКЕТАХ CAS 148553 50 8 СЕРІЇ PREA 260201M PREA 260202M PREA 260203M ВАГА НЕТТО 1200 КГ ВИРОБНИК AURISCO PHARMACEUTICAL CO LTD КРАЇНА ВИРОБНИЦТВА CN
Expand
Trade date
2026/05/26
B/L No.
108277099711
Suppliers
aurisco pharmaceutical co.ltd.
Buyers
công ty cổ phần tập đoàn merap
Product description
СУ СТАНЦІЯ ДЛЯ ФАРМАЦЕВТИЧНОГО ЗАСТОСУВАННЯ ДЛЯ ЛЮДЕЙ АМІНОСПОЛУКИ ПРЕГАБАЛІН PREGABALIN ПОРОШОК СУБСТАНЦІЯ В ПОДВІЙНИХ П Е ПАКЕТАХ CAS 148553 50 8 СЕРІЇ PREA 260101M PREA 260102M ВАГА НЕТТО 1000КГ ВИРОБНИК AURISCO PHARMACEUTICALCO LTD КРАЇНА ВИРОБНИЦТВА CN
Expand
Trade date
2026/05/05
B/L No.
——
Suppliers
aurisco pharmaceutical co.ltd.
Buyers
ms the schazoo pharamaceutical laboratories pvt ltd.
POLs
——
PODs
lpaf
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
2911.994976
Hs code
29372200
Product tags
pharmaceutical,drap,cle,ce certificate,atta,pharmaceutical raw material,aran,fluticasone propionate
Product description
PHARMACEUTICAL RAW MATERIAL FOR THE PHARMACEUTICAL INDUSTRY. FLUTICASONE PROPIONATE WITH W/S (DRAP CLEARANCE CERTIFICATE ATTACHED).
Expand
Trade date
2026/04/28
B/L No.
108191253110
Suppliers
aurisco pharmaceutical co.ltd.
Buyers
công ty cổ phần dược phẩm reliv
Product description
Nguyên liệu dược ABIRATERONE ACETATE tiêu chuẩn NSX, số lô ATAC-260303. SX: 03/2026 - HSD: 02/2029. CK không có nguồn gốc từ tự nhiên,động thực vật, khoáng vật. NSX: Aurisco Pharmaceutical Co.,Ltd.
Expand
Trade date
2026/04/25
B/L No.
20260425-lpi830527kj2-6000543
Suppliers
aurisco pharmaceutical co.ltd.
Buyers
laboratorios pis s.a.de c.v.
Product description
Nguyên liệu Fluticasone Furoate,dùng để sản xuất thuốc Meseca Advanced,tiêu chuẩn nhà sản xuất.Batch No.A28-241204FB31,MFG Date:12/2024,Retest Date:11/2029,hsx:AURISCO PHARMACEUTICAL CO., LTD,Mới 100%
Expand
aurisco pharmaceutical co.ltd. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as pharmaceutical raw material,betamethasone valerate,eplerenone.
According to the 52wmb.com global trade database, as of 2026-06-16, the company has completed 811 international trades,
with its main trading regions covering argentina,pakistan,india etc.
The core products include HS29372200,HS29372900,HS29242190 etc,
often transported via shanghai,port shang hai china republica popular de, port cnsha etc,
and its main trading partners are saffron pharmacueutical pvt ltd.,msn laboratories private,laboratorio lkm s.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on aurisco pharmaceutical co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.